"text-align: center;">Takeda’s Plasma Therapy Against Coronavirus
Pharma Companies Strive To Develop A Coronavirus Drug
Seeking to develop a treatment along with several other drugmakers for the illness that has killed more than 3,000 people, Takeda Pharmaceutical Co said it was developing a drug for the high-risk patients infected with the novel coronavirus.
Takeda Pharma, the Japanese firm said that it was working on a therapy that had previously shown to be effective in treating severe acute viral respiratory infections, the plasma-derived therapy.
Antibodies from the recovered patients or from those who have been vaccinated (once a vaccine is developed) are required for this research.
Takeda said, “A patient’s chance of recovery can be increased by transferring the antibodies to the patient which will help that person’s immune system respond to the infection.
The company said that it is also studying if any of its currently marketed or pipeline products could be used and checked if it is effective in treating the patients with the infection.
Working to develop drugs to treat the Covid-19, Takeda now joins other drugmakers.
Gilead Sciences Inc, a US-based drugmaker said that in patients with severe and moderate cases of the illness, it had started two late-stage studies to test its drug, remdesivir.
Certain antiviral compounds have been developed by Pfizer Inc which have the potential to inhibit coronavirus and to screen the compounds, it is engaging with a third party.
To move its research into the drug forward, Takeda was in talks with various health and regulatory agencies and healthcare partners in the United States, Europe, and Asia and said it would share its plans with members of the US Congress.
To help battle the virus and aid businesses, amid the news of US Congress’ debate and emergency funding, possibly in the range of $6 billion to $8 billion, Takeda made this announcement.
Japan’s biggest pharmaceuticals firm, Takeda’s shares in the company, by market value, was closed down 0.95% prior to the announcement.
Takeda’s plasma therapy against Coronavirus – Source
